XLCARE PHARMACEUTICALS INC - NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.
Key Details
Description
NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.
Context & Analysis
On Feb 5, 2026, Department of Veterans Affairs to XLCARE PHARMACEUTICALS INC for new award for levetiracetam tablets with xlcare pharmaceuticals. ordering period feb 5, 2026 to may 23, 2026, with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 5 offers received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.